UNI-EN 4:2023 Krka Group Performance Estimate and Notification on Establishment of Joint Venture in India
Firma: KRKA, TOVARNA ZDRAVIL D.D.Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
-
2023 Krka Group Performance Estimate.pdf2023 Krka Group Performance Estimate
-
Notification on establishment of a joint venture in India.pdfNotification on establishment of a joint venture in India
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 4 | / | 2024 | |||||||
Date of issue: | 2024-01-25 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
2023 Krka Group Performance Estimate and Notification on Establishment of Joint Venture in India | |||||||||||
Official market - legal basis | |||||||||||
art. 17. 1 MAR. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) releases the 2023 unaudited performance estimates for the Krka Group and notification on establishment of joint venture in India. The press releases with 2023 Krka Group performance estimate and notification on establishment of joint venture in India are attached. This announcement will be published on the company’s website (www.krka.biz) starting from 25 January 2024, for a minimum period of 5 years. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
2023 Krka Group Performance Estimate.pdf 2023 Krka Group Performance Estimate.pdf | 2023 Krka Group Performance Estimate | ||||||||||
Notification on establishment of a joint venture in India.pdf Notification on establishment of a joint venture in India.pdf | Notification on establishment of a joint venture in India |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2024-01-25 | Jože Colarič | President of the management board and CEO |
Cena akcji Krka
Cena akcji Krka w momencie publikacji komunikatu to 508.02 PLN. Sprawdź ile kosztuje akcja Krka aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka.